Hoyoung Huh

Hoyoung Huh, MD/Ph.D., is a Silicon Valley-based entrepreneur and investor who is inspired by innovative science, collaborative creativity, and impact investing. Hoyoung is a global leader in healthcare and technology-based businesses, having founded or grown more than 20 innovative companies. He founded Hannol Ventures, pH Pharma, and the Healthcare and Humanity Foundation. He is currently the Chairman/CEO of pH Pharma, as well as the Chairman of Geron Corporation (NASDAQ: GERN), CytomX Therapeutics (NASDAQ:CTMX), and AntriaBio (OTC:ANTB), and Shared-X in Peru. Dr. Huh holds a B.S. in biochemistry from Dartmouth College, an M.D. from Cornell University Medical College, and a Ph.D. in genetics/cell biology from Cornell University/Sloan-Kettering Institute.